TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02205723

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Asthma teaching in ER
Description: Asthma teaching

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma teaching in ER
Description: Asthma teaching

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smartphone Asthma Control
Description: Smartphone Asthma Control
Study: NCT06545721

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adjusting dietary structure + exercise + behavioral intervention
Description: Adjusting to a healthy diet involves consuming low GI and low-fat foods, avoiding sugary drinks, increasing dietary fiber intake, reducing saturated fat while increasing omega-3 unsaturated fat intake, and limiting trans fat consumption. A weight loss program includes a high-protein diet, exercise, and behavioral intervention with daily total energy needs calculated based on ideal body weight (kg) x 15-20 kcal/kg/d; developing a daily meal plan with regular protein supplementation; limiting salt intake to ≤5 g/d; ensuring adequate water consumption at 2-3L/d; aiming for a dietary fiber intake of 25-30g/d; recommending micronutrient supplementation as needed; maintaining daily aerobic exercise (40 minutes at 70-80% HRmax) along with resistance training (20 minutes); establishing an early bedtime before 11pm and an early wake-up time.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adjusting dietary structure + exercise + behavioral intervention
Description: Adjusting to a healthy diet involves consuming low GI and low-fat foods, avoiding sugary drinks, increasing dietary fiber intake, reducing saturated fat while increasing omega-3 unsaturated fat intake, and limiting trans fat consumption. A weight loss program includes a high-protein diet, exercise, and behavioral intervention with daily total energy needs calculated based on ideal body weight (kg) x 15-20 kcal/kg/d; developing a daily meal plan with regular protein supplementation; limiting salt intake to ≤5 g/d; ensuring adequate water consumption at 2-3L/d; aiming for a dietary fiber intake of 25-30g/d; recommending micronutrient supplementation as needed; maintaining daily aerobic exercise (40 minutes at 70-80% HRmax) along with resistance training (20 minutes); establishing an early bedtime before 11pm and an early wake-up time.
Study: NCT04809168

Intervention type: OTHER
Intervention: Questionnaires and inventories
Description: questionnaires and inventories related to primary end secondary outcomes will be applied and physical examination will be performed.

Intervention type: OTHER
Intervention: Questionnaires and inventories
Description: questionnaires and inventories related to primary end secondary outcomes will be applied and physical examination will be performed.
Study: NCT04675762

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fingolimod
Description: Patients randomized to fingolimod will also receive fingolimod (Gilenya, Novartis) at a dosage of 0.5 mg once daily, for three consecutive days, with the first dose being given at the time in which patients are enrolled which is about one hour prior to mechanical thrombectomy.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients randomized to fingolimod will also receive placebo once daily, for three consecutive days, with the first dose being given at the time in which patients are enrolled which is about one hour prior to mechanical thrombectomy.
Study: NCT05524415

Intervention type: DEVICE
Intervention: Neurosteer EEG recorder
Description: The system is composed of hardware and software modules that facilitate the capture and interpretation of electrophysiological data as well as enable viewing the processed data in real time and offline. An electrode patch is attached on the subject's forehead to capture the electrophysiological signal. The signal is sent via low energy Bluetooth to an EEG Monitor. The signal is then sent via Wi-Fi to the cloud where the data is stored on a HIPAA compliant server. Data analysis performed in the cloud transforms the electrophysiological signal into easily readable data of brain activity.
Study: NCT04772313

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pegloticase
Description: Participants will receive pegloticase with MTX for up to 24 weeks during the treatment period. Participants may opt to receive pegloticase with MTX for an additional 24 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Description: Participants will receive MTX during the run-in period then pegloticase with MTX for up to 24 weeks during the treatment period. Participants may opt to receive pegloticase with MTX for an additional 24 weeks.
Study: NCT05183243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GH21 Capsule
Description: GH21 for oral administration at doses of Dose A, Dose B, Dose C, Dose D, Dose E and Dose F.
Study: NCT05645744

Intervention type: BIOLOGICAL
Intervention: Prior MB-102 CAR-T cell investigational product.
Description: No investigational product will be administered.

Intervention type: BIOLOGICAL
Intervention: Prior MB-106 CAR-T cell investigational product.
Description: No investigational product will be administered.
Study: NCT05220345

Intervention type: DEVICE
Group type: OTHER
Intervention: colonoscopy assisted by both balloon-Behind The Folds visualizing and Computer assisted detection (CADe)
Description: All participants will be subjected to a colonoscopy procedure, assisted by both G-eye balloon and the Discovery CADe system. Standard of care regarding the colonoscopy procedure will be applied to all study subjects. Any lesions detected during the procedure will be removed directly
Study: NCT05461456

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fexofenadine Hydrochloride Topical Lotion 1% (OP2101)
Description: Intervention:~The amount of study lotion (OP2101) used is 11 grams per subject, equivalent to 22 fingertip units (FTU). The lotion is applied to the subject on back and front of the trunk, both hands (palm and back) and both arms. An SOP for handling and application of the lotion ensures the 11 grams covers 54% of the body surface area (BSA) evenly without residue.~Comment:~The treatment is single-dose and single-treatment. The FTU is used to standardize the amount of cream being applied in clinical research. It is also used in clinical practice and hence connects the objectiveness of the trial to the clinical situation.
Study: NCT06073743

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: The conventional physiotherapy program will be applied 2 days a week, 60 minutes a day for 10 weeks and consist of weight bearing on the upper and lower extremities, strengthening, functional stretching exercises, walking training and balance exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: The conventional physiotherapy program will be applied 2 days a week, 60 minutes a day for 10 weeks and consist of weight bearing on the upper and lower extremities, strengthening, functional stretching exercises, walking training and balance exercises.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Game Based Exercise Training
Description: In the Video Game Based Exercise Training program, in addition to the same conventional physiotherapy application for 30 minutes a day, 2 days a week for 10 weeks, 30 minutes of Microsoft Xbox Kinect video games such as reflex ridge and rallyball are used.
Study: NCT05455190

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fit Together
Description: Fit Together intervention follows a clinic and community partnership model for childhood obesity treatment. Children with obesity will receive standard of care obesity treatment from their usual provider and will also receive a referral to an activity program run out of the local community center. Each session delivers a combination of high-intensity individual exercises, sports and games, and unstructured playtime to help children reach the US Physical Activity guidelines of 60min moderate-to-vigorous physical activity daily. There will also be a nutrition activity session offered regularly.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational materials
Description: Participants will receive a child-friendly cooking magazine mailed quarterly and a local Parks and Recreation program guide.
Study: NCT05198154

Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA detection
Description: High-depth sequencing method is used to detecting ctDNA.
Study: NCT06292793

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pain Coping Information
Description: A 4-minute audio recording providing common pain coping techniques (e.g., ice, rest, medication, surgery).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cyclical Sighing
Description: A 4-minute audio recording consisting of a 1-minute introduction to cyclical sighing followed by a 3-minute cyclical sighing practice.
Study: NCT05353296

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioral therapy for insomnia (CBT-I) program
Description: A self-guided digital program of CBT-I (Somryst) that has been culturally adapted for Spanish-language speakers. Somryst is an interactive and tailored mobile-based program modeled on the primary tenets of face-to-face CBT-I. Patients will be asked to complete six cores (main intervention content) during the 9-week intervention period. The cores provide key content across six domains including behavioral (sleep restriction, stimulus control), cognitive (cognitive restricting), educational (sleep hygiene), overview, and consolidation/relapse prevention.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Minimally Enhanced Usual Care (mEUC)
Description: A minimally enhanced usual care, which will include usual care by patients' Primary Care Provider and a sleep hygiene brochure.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Somryst (culturally adapted)
Description: FDA-authorized digital cognitive behavioral therapy for insomnia (CBT-I) trains your brain for better sleep.
Study: NCT06338254

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: percussion massage therapy
Description: Pregnant women included in this group received a total of 12 sessions of percussion massage therapy, applied to their bilateral lower extremities for four weeks. Percussion massage was applied to both extremities at separate times for 5 minutes each with the Hypervolt device. (Fig. 2) Four muscles in total were focused on; These muscles are medial gastrocnemius, lateral gastrocnemius, peronus longus, and tibialis anterior. Percussion massage was applied in the longitudinal direction of the muscle, from distal to proximal and back to distal, going from posterior to anterior muscle groups. Percussion massage started on the medial side and ended on the lateral side for each muscle. Equal pressure and duration were applied to each muscle.
Study: NCT04785586

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Weight Coaching
Description: Lifestyle intervention based on Healthy Weight Coaching (HWC) is a 52 week long web-based weight loss program consisting of weekly modules, exercises, peer support, and one-on-one coaching. It encompasses themes such as diet, physical activity, coping with stress, sleep, and general health.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Weight Coaching
Description: Lifestyle intervention based on Healthy Weight Coaching (HWC) is a 52 week long web-based weight loss program consisting of weekly modules, exercises, peer support, and one-on-one coaching. It encompasses themes such as diet, physical activity, coping with stress, sleep, and general health.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Weight Coaching
Description: Lifestyle intervention based on Healthy Weight Coaching (HWC) is a 52 week long web-based weight loss program consisting of weekly modules, exercises, peer support, and one-on-one coaching. It encompasses themes such as diet, physical activity, coping with stress, sleep, and general health.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual meetings
Description: Individual sessions via video, offered to the participant at three (3) different time points during the 12 month intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group meetings
Description: Group sessions via video, offered to the participant at three (3) different time points during the 12 month intervention.
Study: NCT05715502

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: brachytherapy
Description: Radiation: focal low dose rate or high dose rate brachytherapy for the lesion with appropriate margin, defined in magnetic resonance or positron emission tomography All recruited participants will be treated with interstitial brachytherapy for local recurrence of prostate cancer. The low dose rate of brachytherapy is used with a total dose of 145 Gy in the clinical target volume for participants after hypofractionated radiotherapy, a high dose rate brachytherapy as monotherapy or boost with external beam radiotherapy The high dose rate brachytherapy with two fractions of 13 Gy in the clinical target volume with a 3 to 14 days break is used after primary low dose rate brachytherapy or external beam radiotherapy alone.
Study: NCT05532683

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Behaviors Group
Description: The proposed intervention will include eight modules across nine weekly group sessions targeting psychoeducation of CHR-P symptoms, goal setting, physical activity, sleep, substance use, nutrition, and evidence-based strategies for stress management. Intervention facilitators will utilize motivational interviewing (MI; Miller \& Rollnick, 2012) strategies to engage youth in goal setting to target change in health promotion behaviors. Caregivers will be invited to join at the end of each session for a 10-minute check-out where an outline of content covered and patient goals for the week will be shared.
Study: NCT05674877

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Opioid-based group (OB) (placebo/saline)
Description: Patients in the opioid-based group will receive placebo boluses and infusions of saline.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Opioid sparing group (OS) (dexmedetomidine (PRECEDEX™ dexmedetomidine hydrochloride - Pfizer) and ketamine)
Description: Patients in the Opioid Sparing group will receive a dexmedetomidine (PRECEDEX™ dexmedetomidine hydrochloride - Pfizer) and ketamine.
Study: NCT06277024

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination of Cardonizumab with Lenvatinib and SOX regimen
Description: Phase 1: Conduct a ramp up test on the dosage of lenvatinib according to the traditional 3+3 design; Phase 2: 6 cycles of treatment with candenizumab+lenvatinib+SOX regimen (Q3W); For patients who have not progressed, they will enter the third stage of maintenance treatment.~Phase 3: Maintenance therapy with candenizumab, lenvatinib, and tigio (Q3W).
Study: NCT05294159

Intervention type: OTHER
Intervention: The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)
Description: The Feasibility and Acceptability of Intervention Measure (FIM and AIM) are used to evaluate the feasibilit and acceptability of our implementation strategies. The FIM and AIM is a validated implementation outcome measure where higher scores indicate greater feasibility and acceptability

Intervention type: OTHER
Intervention: The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)
Description: The Feasibility and Acceptability of Intervention Measure (FIM and AIM) are used to evaluate the feasibilit and acceptability of our implementation strategies. The FIM and AIM is a validated implementation outcome measure where higher scores indicate greater feasibility and acceptability
Study: NCT05928559

Intervention type: OTHER
Intervention: OMRON BF511 Body Composition Monitor
Description: The OMRON BF511 Body Composition Monitor is a digital scale and participants' body compositions will be evaluated with this device. The aerobic capacities of the participants will be evaluated with the Multi-Stage 20 m Shuttle Run Test and the maximum oxygen consumption levels will be calculated with the help of the formula with the data obtained from this test. The trunk extensor muscle endurance of the participants will be evaluated with the Biering-Sorensen Test and the trunk flexor endurance will be evaluated with the Kraus-Weber Test. Participants' M. Quadriceps, M. Hamstring, M. Biceps Brachii and M. Triceps Brachii muscle strengths will be evaluated with MicroFET® 2 hand dynamometer.
Study: NCT04742660

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ammonium Glycyrrhizinate
Description: In control group, we assess the incidence and severity of PONV when participants are aministered ramosetron and placebo. In intervention group, the outcomes are assessed as a result of administration of ramosetron and glycyrrhizin.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ammonium Glycyrrhizinate
Description: In control group, we assess the incidence and severity of PONV when participants are aministered ramosetron and placebo. In intervention group, the outcomes are assessed as a result of administration of ramosetron and glycyrrhizin.
Study: NCT06027502

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Passive Heating
Description: 20 minutes of baseline data collection, up to 45 minutes of immersion in the hot tub to achieve a core temperature of 38.5 degrees celsius, followed by up to 90 minutes of recovery.
Study: NCT05908331

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sirolimus Drug Coated Balloon
Description: Magic TouchTM (Concept Medical) is a semi-compliant sirolimus drug coated balloon (SCB) for PCI, based on a polymer-free and nanocarrier based drug delivery technology.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Plan balloon Angioplasty (POBA)
Description: Plan balloon used to open clogged or narrow coronary arteries due to underlying atherosclerosis
Study: NCT05039567

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: optimal heart team protocol
Description: Heart teams in the experimental group will be established and trained based on the optimal heart team implementation protocol. The protocol included instructions on specialist selection, specialist training, team composition, team training and formal implementation precess.
Study: NCT05745467

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Povidone Iodine 5% Soln,Top,Kit
Description: 5% povidone iodine will be swabbed in patients nares of the experimental group.
Study: NCT02014220

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary treatment
Study: NCT05345847

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Surveillance
Description: Close monitoring of liver enzymes with steroid rescue strategy (watch and wait approach)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Early initiation
Description: Immediate start of high-dose steroids
Study: NCT06095635

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Protocol
Description: ingestion of 500 mg of starch following 30 minutes of exercise (treadmill)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protocol Beet
Description: ingestion of 500 mg of beet extect following 30 minutes of exercise (treadmill)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protocol Resveratrol
Description: ingestion of 500 mg of resveratrol following 30 minutes of exercise (treadmill)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Protocol Beet and Resveratrol
Description: ingestion 500 mg of beet extect and 500 mg of resveratrol following 30 minutes of exercise (treadmill)
Study: NCT04231396

Intervention type: OTHER
Group type: OTHER
Intervention: Audiobooks for hearing loss App
Description: Same as Arm 1
Study: NCT05259410

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TRE
Description: All food eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.
Study: NCT04770740

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin K2 in the form of Menaquinone-7 (MK-7)
Description: Patients will take three tablets of vitamin K2 menaquinone-7 (333mcg) per day. Patients taking vitamin K2 MK-7 will receive the total of 999mcg per day from day 1 until day 14 or discharge, whichever occurs earlier. All subjects can be treated with prophylactic or therapeutic heparin-based (heparin or any low-molecular weight heparin) anticoagulants, according to local hospital protocols. Provided by Kappa Bioscience.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will take three tablets of placebo containing only inactive ingredients per day, from day 1 until day 14 or until discharge, whichever occurs first. The placebo is provided by Kappa Bioscience.
Study: NCT05259410

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MedTRE
Description: A mediterranean style diet will be eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.
Study: NCT05325476

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: JomPrEP App
Description: The JomPreP app will be ideally designed to optimize HIV prevention cascade by providing a virtual platform to access to HIV prevention (e.g., HIV testing and PrEP) and other support services (e.g., mental health). The JomPrEP app will be available on the Apple Store and the Google Play Store for the users to download. However, access to the app will be restricted to the research participant using a unique registration code.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Inactivated JomPrEP app
Description: Participants will have access to the JomPrEP app with major intervention features inactivated. Information and resources for HIV testing, PrEP, and available mental health and addiction services will be available along with access to risk assessment tools. The RA will assist in downloading the app and provide a tutorial in using the assessment tool of the app.
Study: NCT06425094

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Microalgae Extract Capsules
Description: Tetrasol extract
Study: NCT05136144

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SM-020
Description: Topical Akt Inhibitor SM-020 Gel
Study: NCT06425094

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: maltodextrin \& vegetable magnesium stearate
Study: NCT06310226

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epidural electrical spinal cord stimulator
Description: Epidural electrical spinal cord stimulator turned on vs. turned off

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Epidural electrical spinal cord stimulator
Description: Epidural electrical spinal cord stimulator turned on vs. turned off